Gravar-mail: Week 48 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 Infected Women (WAVES Study GS-US-236-0128)